Live Nasdaq Composite: Stocks Sink on Worrisome Q2 Tech Earnings, Oil Retakes $100

Special Report

Merck : MRK

All Merck Articles

1089 Articles

Jon C. Ogg | Oct 8, 2012 at 9:07 AM EDT

Great American Companies That Will Survive the Fiscal Cliff

The coming fiscal cliff represents a huge hurdle for America. Government and private sector forecasters have warned that the expiration…

Douglas A. McIntyre | Sep 27, 2012 at 6:32 AM EDT

Companies That Will Not Be Hurt by the Fiscal Cliff

The fiscal cliff has been described as a potential disaster for the finances of individuals and corporations alike. If Congress…

Jon C. Ogg | Sep 26, 2012 at 10:09 AM EDT

Short Selling Activity in Big Dividend Stocks as Dividend Bubble Inflates (MO, AEP, NLY, T, DUK, KMB, KMP, MRK, PG, RAI, VZ)

Short sellers are still active in the high-dividend names out there. Apparently many are under the impression that the dividend…

Jon C. Ogg | Aug 27, 2012 at 9:53 AM EDT

Short Sellers Target Big Dividend Stocks as Dividend Bubble Inflates (MO, AEP, NLY, T, DUK, KMB, KMP, MRK, PG, RAI, VZ)

Short sellers appear to be increasing their bets against some of the key dividend stocks we track each and every…

Jon C. Ogg | Aug 24, 2012 at 8:25 AM EDT

Top Analyst Upgrades and Downgrades (ANF, AEO, ADSK, BMY, BIP, CPB, DV, IDCC, KMI, MDCO, MRK, OTEX, PCYC, STX, SPLS, VHC)

Jon OggThese are the top analyst calls of upgrades, downgrades and initiations we have seen from Wall St.…

Trey Thoelcke | Jul 27, 2012 at 7:32 AM EDT

U.S. Stock Futures Rise Ahead of Q2 GDP Report

U.S. stocks are poised to open higher as investors await the first reading on second-quarter U.S. GDP, and after encouraging…

Paul Ausick | Jul 26, 2012 at 4:04 PM EDT

24/7 Wall St. Closing Bell — July 26, 2012: Market Jumps on ECB President’s Vow

The three major US stock indexes opened higher this morning following European Central Bank president Mario Draghi’s promise to “do…

Jon C. Ogg | Jul 24, 2012 at 1:43 PM EDT

How ‘At-Risk’ Is Gilead’s HIV/AIDS Drug Dominance? (GILD, MRK, GSK)

GileadGilead Sciences, Inc. (NASDAQ: GILD) has a product chest that includes Atripla, Truvada, Viread, Complera/Eviplera, and Emtriva for the treatment…

Paul Ausick | Jul 18, 2012 at 10:56 AM EDT

Top 10 U.S. Drugs for 2012 First Quarter

Online drug research firm drugs.com today released its list of the top 100 selling drugs in the United States for…

Paul Ausick | Jul 18, 2012 at 8:34 AM EDT

Abbott Labs Stung by Foreign Exchange Rate

Abbott Laboratories (NYSE: ABT) reported second-quarter results this morning that beat the consensus estimate for earnings per share (EPS), but…

Jon C. Ogg | Jul 16, 2012 at 10:43 AM EDT

Looking for the Next Biotech Buyout After Two Drug and Biotech Deals

What usually happens when you get two mergers announced in drugs and biotech in the same day? Investors begin to…

Jon C. Ogg | Jul 12, 2012 at 8:29 AM EDT

Top Analyst Upgrades & Downgrades (ADTN, AMCX, ADM, BBVA, BHP, CSIQ, CVX, DAL, FDO, FDX, HSH, JBLU, LXK, LDK, MRK, PG, RHT, LUV, SPWR, SVU, TSN, UAL, VLO, DIS)

Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Thursday.…

Jon C. Ogg | Jul 10, 2012 at 7:35 AM EDT

Finding the Next Biotech M&A Targets (HGSI, GSK, AMLN, BMY, VRTX, CELG, CBST, AMRN, DNDN, BMRN, VVUS, ARNA, PCYC, VICL, MDGN, AFFX, THRX, RIGL)

More biotech mergers are on the way! That is the verdict of Wall St. There may be patent protection risks…

Jon C. Ogg | Jun 30, 2012 at 9:45 AM EDT

The Long Buyout Valuation of Amylin… A Higher Price Yet To Come?

Some mergers are very straight-forward, and others are just odd. Now we have an answer over whether or not Amylin…

Paul Ausick | Jun 25, 2012 at 4:04 PM EDT

24/7 Wall St. Closing Bell — June 25, 2012: Markets Crushed Nearly 2%

The three major US stock indexes opened lower this morning as markets have begun to reach the conclusion that this…

1 … 56 57 58 59 60 … 73

Merck : MRK

All Merck Articles

Great American Companies That Will Survive the Fiscal Cliff

Companies That Will Not Be Hurt by the Fiscal Cliff

Short Selling Activity in Big Dividend Stocks as Dividend Bubble Inflates (MO, AEP, NLY, T, DUK, KMB, KMP, MRK, PG, RAI, VZ)

Short Sellers Target Big Dividend Stocks as Dividend Bubble Inflates (MO, AEP, NLY, T, DUK, KMB, KMP, MRK, PG, RAI, VZ)

Top Analyst Upgrades and Downgrades (ANF, AEO, ADSK, BMY, BIP, CPB, DV, IDCC, KMI, MDCO, MRK, OTEX, PCYC, STX, SPLS, VHC)

U.S. Stock Futures Rise Ahead of Q2 GDP Report

24/7 Wall St. Closing Bell — July 26, 2012: Market Jumps on ECB President’s Vow

How ‘At-Risk’ Is Gilead’s HIV/AIDS Drug Dominance? (GILD, MRK, GSK)

Top 10 U.S. Drugs for 2012 First Quarter

Abbott Labs Stung by Foreign Exchange Rate

Looking for the Next Biotech Buyout After Two Drug and Biotech Deals

Top Analyst Upgrades & Downgrades (ADTN, AMCX, ADM, BBVA, BHP, CSIQ, CVX, DAL, FDO, FDX, HSH, JBLU, LXK, LDK, MRK, PG, RHT, LUV, SPWR, SVU, TSN, UAL, VLO, DIS)

Finding the Next Biotech M&A Targets (HGSI, GSK, AMLN, BMY, VRTX, CELG, CBST, AMRN, DNDN, BMRN, VVUS, ARNA, PCYC, VICL, MDGN, AFFX, THRX, RIGL)

The Long Buyout Valuation of Amylin… A Higher Price Yet To Come?

24/7 Wall St. Closing Bell — June 25, 2012: Markets Crushed Nearly 2%

Live Nasdaq Composite: Stocks Sink on Worrisome Q2 Tech Earnings, Oil Retakes $100

At $100 Per Barrel, Which Oil Stock Has Dominated in 2026: ExxonMobil, Chevron, or BP?

I’m Buying ‘Fully Priced’ AMD Because The Math Says I Should

Two Blowout Quarters, Two Selloffs: What Tesla and Alphabet Reveal About our Price Target

Why Pulling From Your IRA Before Your Taxable Account Still Costs Retirees Five Figures, Even With No Penalty

Roth Conversion Strategy Cuts $1.5 Million 401(k) Tax Bills in Half for Early Retirees

At $100 Per Barrel, Which Oil Stock Has Dominated in 2026: ExxonMobil, Chevron, or BP?

I’m Buying ‘Fully Priced’ AMD Because The Math Says I Should

Merck : MRK

All Merck Articles

Great American Companies That Will Survive the Fiscal Cliff

Companies That Will Not Be Hurt by the Fiscal Cliff

Short Selling Activity in Big Dividend Stocks as Dividend Bubble Inflates (MO, AEP, NLY, T, DUK, KMB, KMP, MRK, PG, RAI, VZ)

Short Sellers Target Big Dividend Stocks as Dividend Bubble Inflates (MO, AEP, NLY, T, DUK, KMB, KMP, MRK, PG, RAI, VZ)

Top Analyst Upgrades and Downgrades (ANF, AEO, ADSK, BMY, BIP, CPB, DV, IDCC, KMI, MDCO, MRK, OTEX, PCYC, STX, SPLS, VHC)

U.S. Stock Futures Rise Ahead of Q2 GDP Report

24/7 Wall St. Closing Bell — July 26, 2012: Market Jumps on ECB President’s Vow

How ‘At-Risk’ Is Gilead’s HIV/AIDS Drug Dominance? (GILD, MRK, GSK)

Top 10 U.S. Drugs for 2012 First Quarter

Abbott Labs Stung by Foreign Exchange Rate

Looking for the Next Biotech Buyout After Two Drug and Biotech Deals

Top Analyst Upgrades & Downgrades (ADTN, AMCX, ADM, BBVA, BHP, CSIQ, CVX, DAL, FDO, FDX, HSH, JBLU, LXK, LDK, MRK, PG, RHT, LUV, SPWR, SVU, TSN, UAL, VLO, DIS)

Finding the Next Biotech M&A Targets (HGSI, GSK, AMLN, BMY, VRTX, CELG, CBST, AMRN, DNDN, BMRN, VVUS, ARNA, PCYC, VICL, MDGN, AFFX, THRX, RIGL)

The Long Buyout Valuation of Amylin… A Higher Price Yet To Come?

24/7 Wall St. Closing Bell — June 25, 2012: Markets Crushed Nearly 2%

Live Nasdaq Composite: Stocks Sink on Worrisome Q2 Tech Earnings, Oil Retakes $100

At $100 Per Barrel, Which Oil Stock Has Dominated in 2026: ExxonMobil, Chevron, or BP?

I’m Buying ‘Fully Priced’ AMD Because The Math Says I Should

Two Blowout Quarters, Two Selloffs: What Tesla and Alphabet Reveal About our Price Target

Featured Reads

Why Pulling From Your IRA Before Your Taxable Account Still Costs Retirees Five Figures, Even With No Penalty

Roth Conversion Strategy Cuts $1.5 Million 401(k) Tax Bills in Half for Early Retirees